You are here

Article info

Article menu
XML
Basic tumor immunology
Original research
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity

Authors

  • Iuliia Efimova Cell Death Investigation and Therapy Laboratory (CDIT), Department of Human Structure and Repair, Ghent University, Ghent, Belgium Cancer Research Institute Ghent, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Elena Catanzaro Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy PubMed articlesGoogle scholar articles
  • Louis Van der Meeren NanoBioTechnology Laboratory, Department of Biotechnology, Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Victoria D Turubanova Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russia PubMed articlesGoogle scholar articles
  • Hamida Hammad Laboratory of Mucosal Immunology and Immunoregulation, VIB Center for Inflammation Research, Ghent, Belgium Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Tatiana A Mishchenko Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russia PubMed articlesGoogle scholar articles
  • Maria V Vedunova Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russia PubMed articlesGoogle scholar articles
  • Carmela Fimognari Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy PubMed articlesGoogle scholar articles
  • Claus Bachert Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Frauke Coppieters Center for Medical Genetics Ghent (CMGG), Department of Biomolecular Medicine, Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Steve Lefever Center for Medical Genetics Ghent (CMGG), Department of Biomolecular Medicine, Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Andre G Skirtach Cancer Research Institute Ghent, Ghent, Belgium NanoBioTechnology Laboratory, Department of Biotechnology, Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Olga Krysko Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Dmitri V Krysko Cell Death Investigation and Therapy Laboratory (CDIT), Department of Human Structure and Repair, Ghent University, Ghent, Belgium Cancer Research Institute Ghent, Ghent, Belgium Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russia Department of Pathophysiology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Dmitri V Krysko; dmitri.krysko{at}ugent.be
View Full Text

Citation

Efimova I, Catanzaro E, Van der Meeren L, et al
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Journal for ImmunoTherapy of Cancer 2020;8:e001369. doi: 10.1136/jitc-2020-001369

Publication history

  • Accepted October 16, 2020
  • First published November 13, 2020.
Online issue publication 
November 13, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.